Compounds for the treatment of metabolic disorders

Details Compounds for the treatment of metabolic disorders Compounds for the treatment of metabolic disorders

2005-09-20

2005-09-20

Raymond, Richard L. (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

C514S675000, C514S678000, C514S717000, C560S008000, C560S019000, C560S038000, C560S039000, C560S075000, C560S205000, C564S123000, C564S149000

Reexamination Certificate

active

06946491

ABSTRACT:
Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.

REFERENCES:
patent: 4011321 (1977-03-01), Coates et al.
patent: 4098816 (1978-07-01), Thorne et al.
patent: 4638094 (1987-01-01), Nakai et al.
patent: 4845231 (1989-07-01), Kees
patent: 5817693 (1998-10-01), Cousins et al.
patent: 5948803 (1999-09-01), Maeda et al.
patent: 6555536 (2003-04-01), Burris et al.
patent: 667498 (1965-11-01), None
patent: 9802163 (2000-11-01), None
patent: 1929165 (1969-12-01), None
patent: 2 309 986 (1974-08-01), None
patent: 2459468 (1975-07-01), None
patent: 2512673 (1975-10-01), None
patent: 2527066 (1976-01-01), None
patent: 3012012 (1981-10-01), None
patent: 71399 (1983-02-01), None
patent: 288190 (1988-10-01), None
patent: 393400 (1990-10-01), None
patent: 407891 (1991-01-01), None
patent: 470832 (1992-02-01), None
patent: 2191887 (1974-02-01), None
patent: 1488330 (1977-10-01), None
patent: 47025149 (1972-10-01), None
patent: 50014653 (1975-02-01), None
patent: 52025734 (1977-02-01), None
patent: 55015460 (1980-02-01), None
patent: 56115747 (1981-09-01), None
patent: 61040270 (1986-02-01), None
patent: 01063570 (1989-03-01), None
patent: 04159266 (1992-06-01), None
patent: 05230009 (1993-09-01), None
patent: 10130241 (1998-05-01), None
patent: 01/181281 (2002-12-01), None
patent: WO 88/08418 (1988-11-01), None
patent: WO 92/12123 (1992-07-01), None
patent: WO 93/08799 (1993-05-01), None
patent: 9412181 (1994-06-01), None
patent: WO 94/27993 (1994-12-01), None
patent: WO 95/13262 (1995-05-01), None
patent: WO 97/30017 (1997-08-01), None
patent: WO 98/07681 (1998-02-01), None
patent: WO 98/08836 (1998-03-01), None
patent: WO 98/25608 (1998-06-01), None
patent: 9803505 (1998-10-01), None
patent: WO 99/11255 (1999-03-01), None
patent: 9919291 (1999-04-01), None
patent: WO 99/20275 (1999-04-01), None
patent: 9946232 (1999-09-01), None
patent: WO 99/62520 (1999-12-01), None
patent: 9962520 (1999-12-01), None
patent: WO 00/23409 (2000-04-01), None
patent: WO 00/63161 (2000-10-01), None
patent: WO 01/40170 (2001-06-01), None
patent: WO 01/81340 (2001-11-01), None
patent: WO 02/02119 (2002-01-01), None
patent: WO 02/14291 (2002-02-01), None
patent: WO 02/59077 (2002-08-01), None
patent: 6705655 (1967-10-01), None
Chem ikcal Abstract DN 111:108486.
Chemical Abstract DN 132:22755, also cited as WO 9962520.
Chemical Abstract DN 111:108486, also cited as Kameo et al in Chem. & Phar. Bull. 37/5, 1260-7(1989).
Chemical Abstract DN 65:20620 also cited as Carlo et al BE 667498.
Chemical Abstract DN 128: 154084, also cited as Momose et al WO 9803508.
Chemical Abstract DN 120: 134060, also cited as Sato et al JP05230009.
Chemical Abstract DN 82: 124990, also cited as Franke et al, Helvetica Acta, 58/1, 278-83(1975).
Chemical Abstract DN 131:243262, also cited as Tajima et al WO 9946232.
Chemical Abstract DN 116:214149, also cited as Suzuki et al EP 470832.
Chemical Abstract DN 130:281874, also cited as Shoda et al WO 9919291.
Chemical Abstract DN 122:315098, also cited as Egbertson et al WO 9412181.
Witiak, et al., “Synthesis of Ethyl 6-Substituted-Chroman-and-Chromone-2-carboxylates. A Comparative Structure-Activity Study Employing the 6-Phenyl and Phenoxy Analogs in the Triton Hyperipidemic Rat Model”, Journal Medical Chemistry, vol. 18, No. 9, pp. 934-942, 1975.
Karche, et al., “Electronic Effects in Migratory Groups . . . ”, Journal of Organic Chemistry, vol. 66, No. 19, pp. 6323-6332, 2001. (Abstract).
Poupardin, et al., “First approach to the cycloisodityrosine unit of RA-IV”, Tetrahedron Letters, vol. 42, No. 8, pp. 1523-1526, 2001. (Abstract).
Manthey, et al., “Synthesis of Human Ultraviolet Filter Compounds . . . ”, Journal of Organic Chemistry, vol. 64, No. 11, pp. 3930-3933, 1999. (Abstract).
Wu, et al., “Improvement on the preparation of .beta.-keto esters”, Huaxue Shiji, vol. 20, No. 6, pp. 376-377, 1998. (Abstract).
Wu, et al., “Total syntheses of furoguaiacin and related analogs”, Huaxue Yanjiu Yu Yingyoung, vol. 9, No. 6, pp. 595-599, 1997. (Abstract).
Fadnavis, et al., “Baker's yeast mediated enantiospecific synthesis of anti-(2R,3R) . . . ”, Tetrahedron Asymmetry, vol. 8, No. 24, pp. 4003-4006, 1997. (Abstract).
Wu, et al., “A modification of the Knorr oxidative coupling method for preparation of 1,4-diketones”, Synthetic Communications, vol. 27, No. 2, pp. 331-336, 1997. (Abstract).
Girard, et al. “Syntheses of the syn and anti .alpha .-amino-.beta.-hydroxy acid of vancomycin . . . ”, Tetrahedron Letters, vol. 37, No. 44, pp. 7967-7970, 1996. (Abstract).
Smith, et al., “Synthesis and PAF antagonist activity of some 2,5-diaryltetrahydrofurans incorporating PAF-like functional groups”, European Journal of Medicinal Chemistry, vol. 31, No. 5, pp. 347-358, 1996. (Abstract).
Maruyama, et al., “A synthesis of (.+−.)-pinoresinol and its related compound using potassium persulfate (K2S208) oxidation of benzoylacetates”, Heterocycles, vol. 37, No. 2, pp. 839-845, 1994. (Abstract).
Rao, et al., “Studies on cyclodepsipeptides. Part II. The total synthesis of jaspamide and geodiamolide-D”, Tetrahedron Letters, vol. 34, No. 44, pp. 7085-7088, 1993. (Abstract).
Colotta, et al., “Tricyclic heteroaromatic systems . . . ”, Farmaco, vol. 46, No. 10, pp. 1139-1154, 1991. (Abstract).
Dillard, et al., “(Phenylmethoxy) phenyl derivatives of w-oxo- and w-tetrazolylalkanoic acids . . . ”, J. Med. Chem., vol. 34, No. 9, pp. 2768-2778, 1991. (Abstract).
Bose, et al., “Synthesis of 4-phenylcoumarins fromDalbergia volubilisandExostema caribaeum”, Phytochemistry, vol. 30, No. 7, pp. 2438-2439, 1991. (Abstract).
Bose, et al., “Synthesis of 4-phenylcoumarins”, Indian J. Chem., Sect. B, vol. 29B, No. 5. pp. 422-444, 1990. (Abstract).
Colotta, et al., “Tricyclic heteroaromatic systems . . . ”, J. Med. Chem., vol. 33, No. 9, pp. 2646-2651, 1990. (Abstract).
Kameo, et al., “Studies on hypolipidemic agents, IV. 3-[4-(Phenylthio) benzoyl] propionic acid derivatives”, Chem. Pharm. Bull., vol. 37, No. 5, pp. 1260-1267, 1989. (Abstract).
Colotta, et al., “Tricyclic heteroaromatic systems: synthesis . . . ” J. Pharm. Sci., vol. 78, No. 3, pp. 239-242, 1989. (Abstract).
Tanaka, et al., “Total synthesis of coumarinolignans, aquillochin (cleomiscosin C) and cleomiscosin D”, Chem. Pharm. Bull., vol. 36, No. 10, pp. 3833-3837, 1988. (Abstract).
Parmar, et al., “Synthesis of new naturally occurring 4-phenyl-2H-1-benzopyran-2-ones”, Bull. Chem. Soc. Jpn., vol. 61, No. 6, pp. 2277-2279, 1988. (Abstract).
Colotta, et al., “The correct synthesis of 2,3-dihydro-2-aryl-4-R-[1] benzopyrano [4,3-c] pyrazole-3-ones”, Tetrahedron Letters, vol. 28, No. 43, pp. 5165-5168, 1987. (Abstract).
Tanaka, et al., “Total synthesis of daphneticin, a coumarinolignoid”, Chem. Pharm. Bull., vol. 34, No. 2 pp. 628-632, 1986. (Abstract).
Ahluwalia, et al., “Synthesis of stevenin and melanettin”, Symp. Pap.-IUPAC Int. Symp. Chem. Nat. Prod., 11th, vol. 3, pp. 11-13, 1978. (Abstract).
Yamaguchi, “Degradation of protolignin with metallic sodium in liquid ammonia”, Ringyo Shikenjo Kenkyu Hokoku, vol. 281, pp. 1-78, 1976. (Abstract).
Okumura, et al., “Synthesis of chromone-3-carboxanilides”, Chem. Pharm. Bull., vol. 22, No. 2, pp. 331-336, 1974. (Abstract).
Von Wacek, et al., “Synthesis of methoxylated compounds for a comparative investigation of the stability of methyl ether groups”, Monatsh. Chem, vol. 97, No. 3, pp. 744-753, 1966. (Abstract).
Iwasa, et al., “The preparation of the biosynthetic precursor 3,7-dihydroxy-2, 6-dimethoxyphenthroindolizidine”, J. Nat. Prod., vol. 51, No. 1, pp. 172-175, 199

Affiliated with

Also associated with

Rating

Compounds for the treatment of metabolic disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds for the treatment of metabolic disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds for the treatment of metabolic disorders will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3406955